Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
Rita T. Lawlor, Paola Mattiolo, Andrea Mafficini, Seung‐Mo Hong, Maria Liliana Piredda, Sergio Vincenzo Taormina, Giuseppe Malleo, Giovanni Marchegiani, Antonio Pea, Roberto Salvia, Valentyna Kryklyva, Jae Il Shin, Lodewijk A.A. Brosens, Michèle Milella, Aldo Scarpa, Claudio Luchini (2021). Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions. , 13(13), DOI: https://doi.org/10.3390/cancers13133119.
Article7 days agoTumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
Rita T. Lawlor, Paola Mattiolo, Andrea Mafficini, Seung‐Mo Hong, Maria Liliana Piredda, Sergio Vincenzo Taormina, Giuseppe Malleo, Giovanni Marchegiani, Antonio Pea, Roberto Salvia, Valentyna Kryklyva, Jae Il Shin, Lodewijk A.A. Brosens, Michèle Milella, Aldo Scarpa, Claudio Luchini (2021). Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions. , 13(13), DOI: https://doi.org/10.3390/cancers13133119.
Article7 days agoKRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
Claudio Luchini, Gaetano Paolino, Paola Mattiolo, Maria Liliana Piredda, Alessandro Cavaliere, Marina Gaule, Davide Melisi, Roberto Salvia, Giuseppe Malleo, Jae Il Shin, Sarah Cargnin, Salvatore Terrazzino, Rita T. Lawlor, Michèle Milella, Aldo Scarpa (2020). KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities. , 39(1), DOI: https://doi.org/10.1186/s13046-020-01732-6.
Article7 days ago